These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 35814507)

  • 21. Marked 25-hydroxyvitamin D deficiency is associated with poor prognosis in patients with alcoholic liver disease.
    Trépo E; Ouziel R; Pradat P; Momozawa Y; Quertinmont E; Gervy C; Gustot T; Degré D; Vercruysse V; Deltenre P; Verset L; Gulbis B; Franchimont D; Devière J; Lemmers A; Moreno C
    J Hepatol; 2013 Aug; 59(2):344-50. PubMed ID: 23557869
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New strain of
    Jiang XW; Li YT; Ye JZ; Lv LX; Yang LY; Bian XY; Wu WR; Wu JJ; Shi D; Wang Q; Fang DQ; Wang KC; Wang QQ; Lu YM; Xie JJ; Li LJ
    World J Gastroenterol; 2020 Oct; 26(40):6224-6240. PubMed ID: 33177795
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alcoholic liver disease confers a worse prognosis than HCV infection and non-alcoholic fatty liver disease among patients with cirrhosis: An observational study.
    Marot A; Henrion J; Knebel JF; Moreno C; Deltenre P
    PLoS One; 2017; 12(10):e0186715. PubMed ID: 29077714
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comprehensive lipidomics reveals phenotypic differences in hepatic lipid turnover in ALD and NAFLD during alcohol intoxication.
    Israelsen M; Kim M; Suvitaival T; Madsen BS; Hansen CD; Torp N; Trost K; Thiele M; Hansen T; Legido-Quigley C; Krag A;
    JHEP Rep; 2021 Oct; 3(5):100325. PubMed ID: 34401690
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Flaxseed oil ameliorates alcoholic liver disease via anti-inflammation and modulating gut microbiota in mice.
    Zhang X; Wang H; Yin P; Fan H; Sun L; Liu Y
    Lipids Health Dis; 2017 Feb; 16(1):44. PubMed ID: 28228158
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-Alcoholic Fatty Liver Disease in Overweight Children: Role of Fructose Intake and Dietary Pattern.
    Nier A; Brandt A; Conzelmann IB; Özel Y; Bergheim I
    Nutrients; 2018 Sep; 10(9):. PubMed ID: 30235828
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differences in the genetic backgrounds of patients with alcoholic liver disease and non-alcoholic fatty liver disease.
    Yamamoto K; Kogiso T; Taniai M; Hashimoto E; Tokushige K
    JGH Open; 2019 Feb; 3(1):17-24. PubMed ID: 30834336
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The prevalence of alcoholic and nonalcoholic fatty liver disease in adolescents and young adults in the United States: analysis of the NHANES database.
    Alkhouri N; Almomani A; Le P; Payne JY; Asaad I; Sakkal C; Vos M; Noureddin M; Kumar P
    BMC Gastroenterol; 2022 Jul; 22(1):366. PubMed ID: 35907827
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gut Microbiota and Alcoholic Liver Disease.
    Scarpellini E; Forlino M; Lupo M; Rasetti C; Fava G; Abenavoli L; De Santis A
    Rev Recent Clin Trials; 2016; 11(3):213-9. PubMed ID: 27515958
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alcoholic liver disease/nonalcoholic fatty liver disease index: distinguishing alcoholic from nonalcoholic fatty liver disease.
    Cerović I; Mladenović D; Ješić R; Naumović T; Branković M; Vučević D; Aleksić V; Radosavljević T
    Eur J Gastroenterol Hepatol; 2013 Aug; 25(8):899-904. PubMed ID: 23426271
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of endotoxaemia & gut permeability with complications of acute pancreatitis: Secondary analysis of data.
    Singh N; Sonika U; Moka P; Sharma B; Sachdev V; Mishra SK; Upadhyay AD; Saraya A
    Indian J Med Res; 2019 Jun; 149(6):763-770. PubMed ID: 31496529
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fenretinide Improves Intestinal Barrier Function and Mitigates Alcohol Liver Disease.
    Tang XH; Melis M; Mai K; Gudas LJ; Trasino SE
    Front Pharmacol; 2021; 12():630557. PubMed ID: 33815111
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Total Flavonoids from
    Meng W; Zhao Z; Chen L; Lin S; Zhang Y; He J; Ouyang K; Wang W
    Foods; 2022 Jul; 11(14):. PubMed ID: 35885412
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Correlation analysis of gut microbiota and biochemical indexes in patients with non-alcoholic fatty liver disease].
    Ren SM; Mei L; Huang H; Cao SF; Zhao RH; Zheng PY
    Zhonghua Gan Zang Bing Za Zhi; 2019 May; 27(5):369-375. PubMed ID: 31177662
    [No Abstract]   [Full Text] [Related]  

  • 35. Ethyl glucuronide in hair detects a high rate of harmful alcohol consumption in presumed non-alcoholic fatty liver disease.
    Staufer K; Huber-Schönauer U; Strebinger G; Pimingstorfer P; Suesse S; Scherzer TM; Paulweber B; Ferenci P; Stimpfl T; Yegles M; Datz C; Trauner M
    J Hepatol; 2022 Oct; 77(4):918-930. PubMed ID: 35605744
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Markers of intestinal permeability are already altered in early stages of non-alcoholic fatty liver disease: Studies in children.
    Nier A; Engstler AJ; Maier IB; Bergheim I
    PLoS One; 2017; 12(9):e0183282. PubMed ID: 28880885
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GRHL2 induces liver fibrosis and intestinal mucosal barrier dysfunction in non-alcoholic fatty liver disease via microRNA-200 and the MAPK pathway.
    Wang Y; Zeng Z; Guan L; Ao R
    J Cell Mol Med; 2020 Jun; 24(11):6107-6119. PubMed ID: 32324317
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Protective effect of Saccharomyces boulardii against intestinal mucosal barrier injury in rats with nonalcoholic fatty liver disease].
    Liu YT; Li YQ; Wang YZ
    Zhonghua Gan Zang Bing Za Zhi; 2016 Dec; 24(12):921-926. PubMed ID: 28073414
    [No Abstract]   [Full Text] [Related]  

  • 39. The Effects of Probiotics on Small Intestinal Microbiota Composition, Inflammatory Cytokines and Intestinal Permeability in Patients with Non-Alcoholic Fatty Liver Disease.
    Ayob N; Muhammad Nawawi KN; Mohamad Nor MH; Raja Ali RA; Ahmad HF; Oon SF; Mohd Mokhtar N
    Biomedicines; 2023 Feb; 11(2):. PubMed ID: 36831176
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulatory effect of a Chinese herbal medicine formula on non-alcoholic fatty liver disease.
    Yang JM; Sun Y; Wang M; Zhang XL; Zhang SJ; Gao YS; Chen L; Wu MY; Zhou L; Zhou YM; Wang Y; Zheng FJ; Li YH
    World J Gastroenterol; 2019 Sep; 25(34):5105-5119. PubMed ID: 31558860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.